Thursday, June 22, 2017 7:45:39 PM
Ricardo Cortez, Company Chairman of Amazonas Florestal, Ltd, stated, "Planting this first field is a milestone for our company and officially postures our sub Amazon Hemp in the CBD Hemp Business. The genetics that the company had bought into known as Marquis M1 was proven by our contractors since last year's harvest to have not only an excellent yield of CBD but also not to have surpassed the legal limit of .3 percent of THC in numerous samplings. These genetics are expected to render very positive results and condition Amazon Hemp as a future supplier of CBD Oil, Distillate and to eventually create a lab facility to supply Nanoparticle Islets. These products allow for the confection of quality High CBD edibles through their ability to mix with liquids while eliminating most of the plant taste."
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM